USFDA inspection: Gland Pharma gets EIR for Dundigal Facility Ruchika Sharma16 Jan 2025 3:56 PM ISTHyderabad: Gland Pharma has announced that the Company has received Establishment Inspection Report (EIR) from the US Food and Drug...
JnJ initiates submission of New Drug Application with USFDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer Ruchika Sharma16 Jan 2025 12:30 PM ISTRaritan: Johnson & Johnson has announced it has initiated the submission of an original New Drug Application with the U.S. Food and Drug...
USFDA approves Eli Lilly Omvoh for Crohn's disease Ruchika Sharma16 Jan 2025 11:30 AM ISTIndianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz) for...
Mankind Pharma slapped over Rs 2 crore penalty by GST authority Ruchika Sharma15 Jan 2025 4:26 PM ISTNew Delhi: Mankind Pharma has said in a BSE filing that the tax authority in Kolkata has imposed a GST-related penalty of over Rs...
Novartis Entresto US patent upheld by US Court of Appeals Ruchika Sharma15 Jan 2025 3:30 PM ISTBasel: Novartis has announced that the Company is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the...
Pfizer to sell USD 3 billion stake in Haleon Ruchika Sharma15 Jan 2025 2:30 PM ISTPfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 billion) in the British...
Alembic Pharma bags USFDA final approval for schizophrenia drug Brexpiprazole Ruchika Sharma15 Jan 2025 1:30 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...
CDSCO grants license to Time Medical International Ventures (India) for manufacturing, distributing MRI systems Ruchika Sharma15 Jan 2025 12:30 PM ISTVishakapatnam: Time Medical International Ventures (India) Private Limited, a Wholly Owned Subsidiary of Fischer Medical Ventures Limited, a Make...
JnJ to acquire Intra-Cellular Therapies for USD 14.6 billion Ruchika Sharma15 Jan 2025 11:30 AM ISTNew Brunswick: Johnson & Johnson and Intra-Cellular Therapies, Inc. have announced that they have entered into a definitive agreement under...
Pfizer Sasanlimab, BCG combo improves event-free survival in patients with BCG-Naive, High-Risk Non-Muscle Invasive Bladder Cancer Ruchika Sharma15 Jan 2025 10:30 AM ISTNew York: Pfizer Inc. has announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational...
Copycat weight-loss drugs: Eli Lilly sues two medical spas Ruchika Sharma14 Jan 2025 5:28 PM ISTTwo medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide is the main ingredient in...
Eli Lilly to acquire Scorpion Therapeutics mutant-selective PI3Kα inhibitor program Ruchika Sharma14 Jan 2025 4:48 PM ISTIndianapolis: Eli Lilly and Company and Scorpion Therapeutics, Inc., a private biotechnology company developing small molecule...
